In a dimly lit lab at the University of Notre Dame, a tiny protein called PA2854—no wider than a few billionths of a meter—was caught doing something extraordinary: gluing together the protective layers of one of the world’s most stubborn bacteria. This molecular handshake, observed in Pseudomonas aeruginosa, could hold the key to disarming some of the most antibiotic-resistant pathogens on Earth. For patients with cystic fibrosis, where P. aeruginosa infections are common and often deadly, this discovery offers a fragile but real hope.
Gram-negative bacteria like P. aeruginosa, E. coli, and Salmonella are shielded by a complex three-layer envelope that blocks most antibiotics. This fortress-like structure has made them a top priority for researchers battling the global rise of drug resistance. At the heart of this defense is a mysterious link between the outer membrane and the rigid cell wall beneath. Now, after years of detective work, scientists led by Shahriar Mobashery have identified the protein responsible: PA2854, a molecular rivet that fastens the outer membrane lipoprotein OprI directly to the peptidoglycan cell wall.
The breakthrough emerged from a systematic search. Luis F. Avila-Cobian, then a student in Mobashery’s lab, screened 71 proteins in P. aeruginosa that interacted with a key cell wall-modifying enzyme. PA2854 stood out. Structural analysis by Juan A. Hermoso’s team in Madrid confirmed it was a transpeptidase—an enzyme capable of forming strong chemical bonds. Then, doctoral student Amr M. El-Araby proved it in action, using both live bacteria and a reconstituted system with purified components. When PA2854 was disabled, the outer membrane began to bulge and detach, weakening the cell’s defenses.
This isn’t just about one bacterium. Because the structure and function of the envelope are conserved across gram-negative species, the discovery could inform new strategies against Klebsiella, Salmonella, and other dangerous pathogens. “PA2854 functions as a glue, a way that keeps the outer membrane attached to the cell wall, a process that is necessary for the health of the organism,” Mobashery said. By targeting this glue, future drugs might not kill bacteria outright—but instead make them vulnerable again to existing antibiotics.
The work, published in the Journal of the American Chemical Society, is part of a larger effort to map the biochemical machinery of bacteria, gene by gene. Each discovery peels back another layer of mystery, turning unknown proteins into potential targets. In a world where superbugs are on the rise, understanding the enemy down to the molecular bolt may be our best defense. And sometimes, the tiniest glue can hold the biggest clue.